With personal genomics hitting the big time, Thomas Mailund wonders about the impact that risk assessments will have on consumer behavior -- and concludes that it will be nominal. Increases in risk of developing a disease such as cancer due to genetics is often small, from 0.1 percent to 0.15 percent, says Mailund. The risk associated with smoking and cancer is much larger, he adds, and that doesn't affect people's behavior, so why would genetics?

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.